+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sudden relief of symptoms in a patient with mesangiocapillary glomerulonephritis during treatment of hematuria with epsilon aminocaproic acid



Sudden relief of symptoms in a patient with mesangiocapillary glomerulonephritis during treatment of hematuria with epsilon aminocaproic acid



Polski Tygodnik Lekarski 46(40-42): 773-774



A case of not expected turn in the course of mesangiocapillary glomerulonephritis in a 30-year old patient is presented. The patient has been treated with EACA. It confirms possible efficiency of EACA inhibitory effect on various immunological reactions. This new, unknown property of EACA justify some new concepts in pathogenetic mechanisms of glomerulopathy.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041485098

Download citation: RISBibTeXText

PMID: 1669156


Related references

Successful epsilon-aminocaproic acid therapy in a patient with unexplained hematuria. Clinical Pediatrics 16(2): 167-168, 1977

Urinary incidents in the treatment of hematuria in hemophiliacs with epsilon-aminocaproic acid. Lille Medical 13(4): 408-412, 1968

Treatment with epsilon aminocaproic acid in persistent hematuria after renal punch biopsy. Semaine Therapeutique 40(4): 273, 1964

Renal complications during treatment of hematuria in hemophilia A with epsilon-aminocaproic acid (EACA). Polski Tygodnik Lekarski 26(4): 145-147, 1971

Treatment of hematuria in a hemophiliac by epsilon aminocaproic acid with concomitant urokinase determination. Bibliotheca Haematologica 26: 114-114, 1966

Arteriovenous fistula and prolonged hematuria after renal biopsy: treatment with epsilon aminocaproic acid. Canadian Medical Association Journal 110(6): 671, 1974

Treatment of hematuria in hemorrhagic diathesis by means of epsilon-aminocaproic acid with concomitant determination of urokinase. Folia Clinica Internacional 15(11): 537-538, 1965

Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. Journal of Urology 184(3): 1152-1157, 2010

The use of epsilon aminocaproic acid in sickle cell trait hematuria. Journal of Urology 105(4): 552-553, 1971

Sickle cell hematuria controlled by epsilon aminocaproic acid. Connecticut Medicine 39(12): 777-778, 1975

Epsilon-aminocaproic acid in traumatic renal hematuria in the rabbit. Investigative Urology 12(6): 458-460, 1975

Unilateral essential hematuria. Therapy with epsilon aminocaproic acid. Urology 23(3): 297-298, 1984

Epsilon aminocaproic acid therapy of hematuria due to heterozygous sickle cell diseases. Journal of Urology 102(1): 93-95, 1969

Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. II. A clinical study with the aid of intravenous phlebography. Acta Chirurgica Scandinavica 136(3): 167-171, 1970

Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. A study in experimental animals and in clinical material. Acta Chirurgica Scandinavica 134(5): 343-349, 1968